NCT00616772

Brief Summary

The primary purpose of this study is to test the effect and safety of once daily ABT-335 on the thickness of the lining of the carotid artery (a blood vessel to the brain) in patients with abnormal blood lipids who have optimal levels of low density lipoprotein cholesterol ("bad cholesterol") after taking atorvastatin.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
682

participants targeted

Target at P75+ for phase_3 coronary-artery-disease

Timeline
Completed

Started Feb 2008

Typical duration for phase_3 coronary-artery-disease

Geographic Reach
1 country

124 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2008

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

February 5, 2008

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 15, 2008

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2012

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

January 20, 2014

Completed
Last Updated

July 2, 2018

Status Verified

December 1, 2013

Enrollment Period

4.6 years

First QC Date

February 5, 2008

Results QC Date

September 13, 2013

Last Update Submit

June 1, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of Change in Mean Posterior-wall Carotid Intima-media Thickness (cIMT)

    Rate of change (mm/year) from baseline in mean of posterior-wall carotid intima-media thickness (cIMT) of the left and right common carotid artery. The statistical model used change from baseline as the dependent variable, with time of cIMT assessment (in years) as one of the factors in the model. The between-group difference in the rate of change was based on the parameter coefficient for the time-by-treatment interaction. The within-group rate of change was obtained from estimate statements within the repeated measures analysis. cIMT was measured using non-invasive ultrasound.

    Baseline, 6 months, 12 months, 18 months, and 24 months

Secondary Outcomes (4)

  • Rate of Change in Mean of Maximal Posterior-wall Carotid Intima-media Thickness (cIMT)

    Baseline, 6 months, 12 months, 18 months, and 24 months

  • Rate of Change in Composite of Mean of the Mean Posterior-wall Intima-media Thickness (IMT)

    Baseline, 6 months, 12 months, 18 months, and 24 months

  • Rate of Change in Composite of Mean of Maximal Posterior-wall Intima-media Thickness (IMT)

    Baseline, 6 months, 12 months, 18 months, and 24 months

  • Rate of Change in Composite of Mean of Maximal Posterior-wall and Anterior-wall Intima-media Thickness (IMT)

    Baseline, 6 months, 12 months, 18 months, and 24 months

Study Arms (2)

ABT-335 + Atorvastatin

EXPERIMENTAL

ABT-335 (135 mg) and atorvastatin (up to 40 mg) once daily for 2 years.

Drug: ABT-335Other: Atorvastatin

Placebo + Atorvastatin

PLACEBO COMPARATOR

Placebo and atorvastatin (up to 40 mg) once daily for 2 years.

Drug: PlaceboOther: Atorvastatin

Interventions

Capsule

Also known as: Choline fenofibrate, Fenofibric acid
ABT-335 + Atorvastatin

Capsule

Placebo + Atorvastatin

Capsule

ABT-335 + AtorvastatinPlacebo + Atorvastatin

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with mixed dyslipidemia
  • Qualifying cIMT thickness

You may not qualify if:

  • Patients with certain chronic or unstable medical conditions.
  • Patients with unstable dose of medications or receiving coumadin, cyclosporine, or certain other medications
  • Pregnant or lactating women or women intending to become pregnant
  • Patients with diabetes mellitus that is poorly controlled

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (124)

Site Reference ID/Investigator# 6747

Chandler, Arizona, 85225, United States

Location

Site Reference ID/Investigator# 7089

Gilbert, Arizona, 85295, United States

Location

Site Reference ID/Investigator# 7097

Mesa, Arizona, 85206, United States

Location

Site Reference ID/Investigator# 26394

Phoenix, Arizona, 85032, United States

Location

Site Reference ID/Investigator# 6848

Scottsdale, Arizona, 85251, United States

Location

Site Reference ID/Investigator# 7059

Tempe, Arizona, 85282, United States

Location

Site Reference ID/Investigator# 7094

Tempe, Arizona, 85282, United States

Location

Site Reference ID/Investigator# 7098

Tempe, Arizona, 85282, United States

Location

Site Reference ID/Investigator# 25082

Anaheim, California, 92804, United States

Location

Site Reference ID/Investigator# 21347

Corona, California, 92879-3109, United States

Location

Site Reference ID/Investigator# 21483

Garden Grove, California, 92843, United States

Location

Site Reference ID/Investigator# 21351

Huntington Beach, California, 92648, United States

Location

Site Reference ID/Investigator# 21346

Laguna Hills, California, 92653, United States

Location

Site Reference ID/Investigator# 21341

Long Beach, California, 90806, United States

Location

Site Reference ID/Investigator# 21342

Norwalk, California, 90650, United States

Location

Site Reference ID/Investigator# 21321

Santa Ana, California, 92705, United States

Location

Site Reference ID/Investigator# 26242

Tustin, California, 92780, United States

Location

Site Reference ID/Investigator# 15283

Arvada, Colorado, 80005-3927, United States

Location

Site Reference ID/Investigator# 7085

Aurora, Colorado, 80012, United States

Location

Site Reference ID/Investigator# 6749

Denver, Colorado, 80239, United States

Location

Site Reference ID/Investigator# 7077

Denver, Colorado, 80246, United States

Location

Site Reference ID/Investigator# 7092

Golden, Colorado, 80401, United States

Location

Site Reference ID/Investigator# 7722

Littleton, Colorado, 80122, United States

Location

Site Reference ID/Investigator# 7721

Littleton, Colorado, 80127, United States

Location

Site Reference ID/Investigator# 11925

Aventura, Florida, 33180, United States

Location

Site Reference ID/Investigator# 15861

Boynton Beach, Florida, 33472, United States

Location

Site Reference ID/Investigator# 14422

Deerfield Beach, Florida, 33442, United States

Location

Site Reference ID/Investigator# 19281

Delray Beach, Florida, 33445, United States

Location

Site Reference ID/Investigator# 20881

Hollywood, Florida, 33021, United States

Location

Site Reference ID/Investigator# 20882

Kissimmee, Florida, 34741, United States

Location

Site Reference ID/Investigator# 19321

Melbourne, Florida, 32901, United States

Location

Site Reference ID/Investigator# 21353

Melbourne, Florida, 32901, United States

Location

Site Reference ID/Investigator# 18503

Melbourne, Florida, 32935, United States

Location

Site Reference ID/Investigator# 18841

Vero Beach, Florida, 32960, United States

Location

Site Reference ID/Investigator# 19961

Vero Beach, Florida, 32960, United States

Location

Site Reference ID/Investigator# 7166

West Palm Beach, Florida, 33401, United States

Location

Site Reference ID/Investigator# 6744

West Palm Beach, Florida, 33407, United States

Location

Site Reference ID/Investigator# 19301

Atlanta, Georgia, 30308, United States

Location

Site Reference ID/Investigator# 7051

Atlanta, Georgia, 30342-1524, United States

Location

Site Reference ID/Investigator# 7109

Atlanta, Georgia, 30342, United States

Location

Site Reference ID/Investigator# 7326

Dawsonville, Georgia, 30534, United States

Location

Site Reference ID/Investigator# 7325

Decatur, Georgia, 30033, United States

Location

Site Reference ID/Investigator# 7057

Dunwoody, Georgia, 30338, United States

Location

Site Reference ID/Investigator# 7101

Dunwoody, Georgia, 30338, United States

Location

Site Reference ID/Investigator# 11324

Roswell, Georgia, 30076, United States

Location

Site Reference ID/Investigator# 6741

Roswell, Georgia, 30076, United States

Location

Site Reference ID/Investigator# 7103

Suwanee, Georgia, 30024, United States

Location

Site Reference ID/Investigator# 10761

Addison, Illinois, 60101, United States

Location

Site Reference ID/Investigator# 6748

Aurora, Illinois, 60504, United States

Location

Site Reference ID/Investigator# 6742

Aurora, Illinois, 60506, United States

Location

Site Reference ID/Investigator# 7128

Belleville, Illinois, 62220-1986, United States

Location

Site Reference ID/Investigator# 7069

Chicago, Illinois, 60607, United States

Location

Site Reference ID/Investigator# 6849

Chicago, Illinois, 60612-9985, United States

Location

Site Reference ID/Investigator# 6867

Chicago, Illinois, 60612, United States

Location

Site Reference ID/Investigator# 6751

Chicago, Illinois, 60616, United States

Location

Site Reference ID/Investigator# 6847

Chicago, Illinois, 60631, United States

Location

Site Reference ID/Investigator# 7049

Chicago, Illinois, 60654, United States

Location

Site Reference ID/Investigator# 7093

Gurnee, Illinois, 60031, United States

Location

Site Reference ID/Investigator# 6746

Hazel Crest, Illinois, 60429, United States

Location

Site Reference ID/Investigator# 6743

Melrose Park, Illinois, 60160, United States

Location

Site Reference ID/Investigator# 7090

Naperville, Illinois, 60564, United States

Location

Site Reference ID/Investigator# 6750

Oak Brook, Illinois, 60523, United States

Location

Site Reference ID/Investigator# 6788

Oak Park, Illinois, 60304, United States

Location

Site Reference ID/Investigator# 6927

Vernon Hills, Illinois, 60061, United States

Location

Site Reference ID/Investigator# 7076

Erlanger, Kentucky, 41018, United States

Location

Site Reference ID/Investigator# 8103

Bloomington, Minnesota, 55420, United States

Location

Site Reference ID/Investigator# 15121

Brooklyn Center, Minnesota, 55430, United States

Location

Site Reference ID/Investigator# 7050

Edina, Minnesota, 55435, United States

Location

Site Reference ID/Investigator# 7084

Edina, Minnesota, 55435, United States

Location

Site Reference ID/Investigator# 6784

City of Saint Peters, Missouri, 63376, United States

Location

Site Reference ID/Investigator# 6860

St Louis, Missouri, 63110, United States

Location

Site Reference ID/Investigator# 13182

St Louis, Missouri, 63117, United States

Location

Site Reference ID/Investigator# 14423

St Louis, Missouri, 63128, United States

Location

Site Reference ID/Investigator# 14541

St Louis, Missouri, 63141-6399, United States

Location

Site Reference ID/Investigator# 6740

St Louis, Missouri, 63141, United States

Location

Site Reference ID/Investigator# 7053

St Louis, Missouri, 63141, United States

Location

Site Reference ID/Investigator# 7063

Henderson, Nevada, 89014, United States

Location

Site Reference ID/Investigator# 7070

Henderson, Nevada, 89052, United States

Location

Site Reference ID/Investigator# 7106

Las Vegas, Nevada, 89104, United States

Location

Site Reference ID/Investigator# 7518

Las Vegas, Nevada, 89106, United States

Location

Site Reference ID/Investigator# 7119

Las Vegas, Nevada, 89146, United States

Location

Site Reference ID/Investigator# 7129

Las Vegas, Nevada, 89148, United States

Location

Site Reference ID/Investigator# 7071

Cincinnati, Ohio, 45212, United States

Location

Site Reference ID/Investigator# 7100

Cincinnati, Ohio, 45219, United States

Location

Site Reference ID/Investigator# 14321

Cincinnati, Ohio, 45224, United States

Location

Site Reference ID/Investigator# 21355

Cincinnati, Ohio, 45245, United States

Location

Site Reference ID/Investigator# 7074

Cincinnati, Ohio, 45246, United States

Location

Site Reference ID/Investigator# 7065

Cincinnati, Ohio, 45249, United States

Location

Site Reference ID/Investigator# 7075

Dayton, Ohio, 45439, United States

Location

Site Reference ID/Investigator# 24802

Kettering, Ohio, 45429, United States

Location

Site Reference ID/Investigator# 7068

Mason, Ohio, 45040, United States

Location

Site Reference ID/Investigator# 7104

Bellaire, Texas, 77401, United States

Location

Site Reference ID/Investigator# 7060

Carrollton, Texas, 75006-5810, United States

Location

Site Reference ID/Investigator# 15282

Dallas, Texas, 75230, United States

Location

Site Reference ID/Investigator# 6745

Dallas, Texas, 75231, United States

Location

Site Reference ID/Investigator# 7083

Dallas, Texas, 75231, United States

Location

Site Reference ID/Investigator# 7127

Dallas, Texas, 75231, United States

Location

Site Reference ID/Investigator# 7110

Dallas, Texas, 75251, United States

Location

Site Reference ID/Investigator# 21356

Deer Park, Texas, 77536, United States

Location

Site Reference ID/Investigator# 11923

Fort Worth, Texas, 76116, United States

Location

Site Reference ID/Investigator# 7321

Houston, Texas, 77002, United States

Location

Site Reference ID/Investigator# 21354

Houston, Texas, 77024, United States

Location

Site Reference ID/Investigator# 21358

Houston, Texas, 77030, United States

Location

Site Reference ID/Investigator# 26482

Houston, Texas, 77030, United States

Location

Site Reference ID/Investigator# 7079

Houston, Texas, 77030, United States

Location

Site Reference ID/Investigator# 7096

Houston, Texas, 77030, United States

Location

Site Reference ID/Investigator# 7126

Houston, Texas, 77036, United States

Location

Site Reference ID/Investigator# 8186

Houston, Texas, 77036, United States

Location

Site Reference ID/Investigator# 11323

Houston, Texas, 77074, United States

Location

Site Reference ID/Investigator# 7130

Houston, Texas, 77081, United States

Location

Site Reference ID/Investigator# 11924

Irving, Texas, 75039, United States

Location

Site Reference ID/Investigator# 13863

Irving, Texas, 75061, United States

Location

Site Reference ID/Investigator# 7099

McKinney, Texas, 75069, United States

Location

Site Reference ID/Investigator# 19121

New Braunfels, Texas, 78130, United States

Location

Site Reference ID/Investigator# 26244

Pearland, Texas, 77584, United States

Location

Site Reference ID/Investigator# 7105

Plano, Texas, 75024, United States

Location

Site Reference ID/Investigator# 7061

San Antonio, Texas, 78205, United States

Location

Site Reference ID/Investigator# 7320

San Antonio, Texas, 78215, United States

Location

Site Reference ID/Investigator# 7914

San Antonio, Texas, 78218, United States

Location

Site Reference ID/Investigator# 7058

San Antonio, Texas, 78229-4801, United States

Location

Site Reference ID/Investigator# 18402

San Antonio, Texas, 78229, United States

Location

Site Reference ID/Investigator# 7052

San Antonio, Texas, 78229, United States

Location

Site Reference ID/Investigator# 7062

San Antonio, Texas, 78229, United States

Location

Site Reference ID/Investigator# 22947

San Antonio, Texas, 78238-1434, United States

Location

Related Publications (1)

  • Davidson M, Rosenson RS, Maki KC, Nicholls SJ, Ballantyne CM, Setze C, Carlson DM, Stolzenbach J. Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial. Cardiovasc Drugs Ther. 2012 Aug;26(4):349-58. doi: 10.1007/s10557-012-6395-z.

Related Links

MeSH Terms

Conditions

Coronary Artery DiseaseCoronary DiseaseDyslipidemias

Interventions

2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoic acidfenofibric acidAtorvastatin

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

PyrrolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeptanoic AcidsFatty AcidsLipids

Results Point of Contact

Title
Global Medical Services
Organization
AbbVie (prior sponsor, Abbott)

Study Officials

  • Maureen Kelly, MD

    AbbVie

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 5, 2008

First Posted

February 15, 2008

Study Start

February 1, 2008

Primary Completion

September 1, 2012

Study Completion

September 1, 2012

Last Updated

July 2, 2018

Results First Posted

January 20, 2014

Record last verified: 2013-12

Locations